Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray.
Liyuan DaiHaizhu ChenQiaoyun TanYanrong WangLin LiNing LouGuangyu FanTongji XieRongrong LuoShasha WangYu ZhouQiaofeng ZhongJiarui YaoZhishang ZhangLe TangYuan-Kai ShiXiao-Hong HanPublished in: Cancer (2023)
This study identified a novel prognostic panel of CREB1, N4BP1, DEAF1, and UBAP2 AAbs that is independent of the IPI in DLBCL.